NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Ortin Laboratories Limited (NSE: ORTINLABSS)
ORTINLABSS Technical Analysis
1
As on N/A ORTINLABSS SHARE Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS. |
ORTINLABSSSHARE Price
Open | N/A | Change | Price | % |
High | N/A | 1 Day | N/A | N/A |
Low | N/A | 1 Week | N/A | N/A |
Close | N/A | 1 Month | N/A | N/A |
Volume | N/A | 1 Year | N/A | N/A |
52 Week High N/A | 52 Week Low N/A |
NSE INDIA Most Active Stocks
IDEA | 14.00 | 0.72% |
YESBANK | 26.15 | 0.77% |
IRFC | 158.05 | 5.19% |
GMRINFRA | 90.75 | 6.58% |
HUDCO | 228.10 | 12.34% |
MAHABANK | 67.65 | 3.68% |
SAIL | 168.55 | 2.18% |
NHPC | 92.55 | 1.65% |
TATASTEEL | 165.80 | -1.13% |
IDFCFIRSTB | 84.80 | 1.68% |
NSE INDIA Top Gainers Stocks
ROSSELLIND | 468.35 | 20.00% |
MGEL | 23.25 | 19.85% |
KIRLOSIND | 5232.65 | 12.84% |
HUDCO | 228.10 | 12.34% |
DPABHUSHAN | 1133.45 | 10.42% |
KECL | 130.60 | 10.30% |
EXCEL | 0.55 | 10.00% |
ACL | 98.15 | 9.79% |
ACL | 98.15 | 9.79% |
ACL | 98.15 | 9.79% |
NSE INDIA Top Losers Stocks
LTTS | 4778.10 | -7.81% |
BAJFINANCE | 6731.20 | -7.73% |
DBSTOCKBRO | 50.90 | -5.91% |
COMPUSOFT | 33.95 | -5.56% |
KSB | 4674.75 | -5.21% |
KSB | 4674.75 | -5.21% |
KSB | 4674.75 | -5.21% |
KSB | 4674.75 | -5.21% |
KSB | 4674.75 | -5.21% |
KSB | 4674.75 | -5.21% |
ORTINLABSS Daily Charts |
ORTINLABSS Intraday Charts |
Whats New @ Bazaartrend |
ORTINLABSS Free Analysis |
|
ORTINLABSS Important Levels Intraday
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE |
ORTINLABSS Target April 2024
4th UP Target | |
3rd UP Target | |
2nd UP Target | |
1st UP Target | |
1st DOWN Target | |
2nd DOWN Target | |
3rd DOWN Target | |
4th DOWN Target |
ORTINLABSS Weekly Target
4th UP Target | |
3rd UP Target | |
2nd UP Target | |
1st UP Target | |
1st DOWN Target | |
2nd DOWN Target | |
3rd DOWN Target | |
4th DOWN Target |
ORTINLABSS Target2024
4th UP Target | |
3rd UP Target | |
2nd UP Target | |
1st UP Target | |
1st DOWN Target | |
2nd DOWN Target | |
3rd DOWN Target | |
4th DOWN Target |
Ortin Laboratories Limited ( NSE INDIA Symbol : ORTINLABSS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ORTINLABSS Synopsis Technicals View
50 Day EMA |
Close is Below EMA 50 (Short Term) |
Bearish | |
100 Day EMA | Close is Below EMA 100 (Mid Term) | Bearish | |
200 Day EMA | Close is Below EMA 200 (Long Term) | Bearish | |
MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
RSI (14) | RSI is 42.96 | Sideways | |
MFI (14) | MFI is 46.54 | Sideways | |
CCI (20) | CCI is Below -100 | Over Sold | |
WILLIAM %R (14) | William %R is -68.89 | Sideways | |
ADX (14) | ADX is 10.43 | Range Bound | |
PSAR | Stoploss For Short Sell | 8.80 | |
10 Day Avg Volume | Traded 89.28 % More then 10 Day Average Volume |
ORTINLABSS Other Details
Segment | EQ | |
Market Capital | 132313888.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
ORTINLABSS Address
ORTINLABSS Latest News
ORTINLABSS Business Profile
Ortin Laboratories Limited manufactures and trades in pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti biotics-quinolones, anti biotic-pencillins, cephalosporins, and macrolides; and anti anginal and cardio vascular, and antifungal products. The company's formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium preparations, iron preparations, anti arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti retroviral products. In addition, it provides active pharmaceutical ingredient (API) intermediates comprising anti retro viral, anti diabetics, analgesics and antipyretics, anti biotic, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company offers services in the areas of process development, process characterization, analytical research and development, assay development, and product characterization; and diagnostic services, including development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. Ortin Laboratories Limited was founded in 1986 and is based in Hyderabad, India. Address: Door No. 3-4-512/35 (43/4RT), Hyderabad, India, 500 027
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service